Back to User profile » Dr Peize Zhang

Papers published by Dr Peize Zhang:


Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication

Fu L, Wang W, Xiong J, Zhang P, Li H, Zhang X, Liang H, Yang Q, Wang Z, Chen X, Deng G, Cai Y, Tang S

Infection and Drug Resistance 2024, 17:595-604

Published Date: 17 February 2024

Pharmacokinetics of Antituberculosis Drugs in Plasma and Cerebrospinal Fluid in a Patient with Pre-Extensive Drug Resistant Tuberculosis Meningitis

Liang Z, Liao W, Chen Q, Li H, Ye M, Zou J, Deng G, Zhang P

Infection and Drug Resistance 2023, 16:1669-1676

Published Date: 23 March 2023

A Rare Case of Post-Primary Tuberculosis Which Was Pathologically Diagnosed as Lipoid Pneumonia

Yu M, Zhong J, Bu X, Tan X, Zhan D, Hu X, Gu Y, Xu J, Zhang P, Wang L

Infection and Drug Resistance 2022, 15:4235-4239

Published Date: 4 August 2022

Duration and Determinants of Delayed Diagnosis with Tuberculosis in Shenzhen, China: A Cross-Sectional Study

Jiang Y, Luo L, Gui M, Liu L, Lin Y, Deng G, Chen J, Zhang P

Risk Management and Healthcare Policy 2022, 15:1473-1481

Published Date: 29 July 2022

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China

Zhang P, Li W, Liu M, Zhan S, Zhang H, Deng G, Chen X

Infection and Drug Resistance 2022, 15:2617-2624

Published Date: 23 May 2022

Extensive Radiological Manifestation in Patients with Diabetes and Pulmonary Tuberculosis: A Cross-Sectional Study

Zhan S, Juan X, Ren T, Wang Y, Fu L, Deng G, Zhang P

Therapeutics and Clinical Risk Management 2022, 18:595-602

Published Date: 23 May 2022

Performance of Xpert MTB/RIF Ultra for the Diagnosis of Pulmonary Tuberculosis Using Bronchoalveolar Lavage Samples in People Living with HIV/AIDS (PLWHA) in China: A Prospective Study

Zhang P, Liu M, Wang H, Wu Y, Sun L, Rao M, Jia X, Song Y, Deng G, Li T, Ye F, Zhou Y, Liao Y

HIV/AIDS - Research and Palliative Care 2021, 13:905-916

Published Date: 10 September 2021

Factors Associated with Medical Follow-Up Adherence for Patients on All-Oral Regimen for Multidrug-Resistant Tuberculosis in Shenzhen, China

Li H, Zhang H, Xiong J, Wang Y, Wang W, Wang J, Lin Y, Zhang P

Patient Preference and Adherence 2021, 15:1491-1496

Published Date: 5 July 2021

Clinical Evaluation of Active Tuberculosis-Related Deaths in Shenzhen, China: A Descriptive Study

Zhang P, Xiong J, Zeng J, Zhan S, Chen T, Wang Y, Deng G

International Journal of General Medicine 2021, 14:237-242

Published Date: 22 January 2021

Challenges Faced by Multidrug-Resistant Tuberculosis Patients in Three Financially Affluent Chinese Cities

Zhang P, Xu G, Song Y, Tan J, Chen T, Deng G

Risk Management and Healthcare Policy 2020, 13:2387-2394

Published Date: 2 November 2020

Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report

He W, Zhang XM, Li WW, Kong C, Wang YY, Zhu LY, Xu RL, Deng GF, Zhang PZ

OncoTargets and Therapy 2018, 11:7423-7427

Published Date: 24 October 2018